Accelerating biomedical research through open knowledge creation and stewardship

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 6, 2013, Pages 476-478

  Wagner, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C;

ARTICLE; GLYCEMIC CONTROL; HUMAN; KNOWLEDGE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ADVOCACY; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; HUMANS; MODELS, ORGANIZATIONAL;

EID: 84878241716     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.56     Document Type: Article

References (5)

1. Woodcock, J. Precompetitive research: a new prescription for drug development? Clin. Pharmacol. Ther. 87, 521-523 (2010).
2. Weber, S. The Success of Open Source (Harvard University Press, Cambridge, MA, 2004).
3. Huang, R. et al. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci. Transl. Med. 3, 80ps16 (2011).
4. Matsuo, M. et al. Efects of cyclodextrin in two patients with Niemann-Pick Type C disease. Mol. Genet. Metab. 108, 76-81 (2013).
5. Wagner, J.A. et al. Utility of adiponectin as a biomarker predictive of glycemic efcacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin. Pharmacol. Ther. 86, 619-625 (2009).